Ipilimumab/nivolumabHypophysitis with panhypopituitarism, central diabetes insipidus and type 1 diabetes mellitus: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1734卷 / 1期

关键词：

D O I：

10.1007/s40278-019-56418-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：293 / 293

相关论文

共 50 条

[21] Ipilimumab/nivolumabType-1 diabetes mellitus: case report
Reactions Weekly, 2023, 1977 (1) : 172 - 172
[22] Ipilimumab/nivolumabAutoimmune diabetes mellitus: case report
Reactions Weekly, 2018, 1714 (1) : 239 - 239
[23] Ipilimumab/nivolumabHypophysitis: case report
Reactions Weekly, 2022, 1887 (1) : 396 - 396
[24] Interferon-beta/ipilimumab/nivolumabFulminant type 1 diabetes mellitus: case report
Reactions Weekly, 2018, 1715 (1) : 140 - 140
[25] Ipilimumab/pembrolizumabFulminant type 1 diabetes: case report
Reactions Weekly, 2016, 1603 (1) : 157 - 157
[26] Pituitary Metastasis Presenting With Central Diabetes Insipidus and Panhypopituitarism
Parthasarathy, Sahana
Lee, Donna H.
Levitt, Alex H.
Manavalan, Anjali
AACE CLINICAL CASE REPORTS, 2022, 8 (01): : 15 - 18
[27] Ipilimumab/nivolumabFulminant type 1 diabetes: case report
Reactions Weekly, 2017, 1656 (1) : 280 - 280
[28] Ipilimumab/nivolumabHypophysitis: case report
Reactions Weekly, 2022, 1926 (1) : 277 - 277
[29] Ipilimumab/nivolumabHypophysitis: case report
Reactions Weekly, 2021, 1843 (1) : 210 - 210
[30] SARCOIDOSIS WITH PANHYPOPITUITARISM AND DIABETES INSIPIDUS
NORA, JR
LEVITSKY, JM
ZIMMERMAN, HJ
ANNALS OF INTERNAL MEDICINE, 1959, 51 (06) : 1400 - 1409

← 1 2 3 4 5 →